Connection
David Hall to Humans
This is a "connection" page, showing publications David Hall has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.082 |
|
|
|
-
Behringer MG, Hall DW. Selection on Position of Nonsense Codons in Introns. Genetics. 2016 11; 204(3):1239-1248.
Score: 0.012
-
Stanger-Hall KF, Hall DW. Abstinence-only education and teen pregnancy rates: why we need comprehensive sex education in the U.S. PLoS One. 2011; 6(10):e24658.
Score: 0.009
-
Moorad JA, Hall DW. Mutation accumulation, soft selection and the middle-class neighborhood. Genetics. 2009 Aug; 182(4):1387-9.
Score: 0.007
-
Ortendahl JD, Carter GC, Zantema EM, Hoag JR, Starodynov A, White KL, Basu GD, Tharayanil A, De La O JP, Hall DW, Baehner FL. Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. J Med Econ. 2026 Dec; 29(1):1046-1058.
Score: 0.006
-
De La O JP, Hoag JR, Deem AK, Wang M, Starodynov A, Udhane SS, LoBello JR, Therala N, Hall DW, Basu GD, Baehner FL. Comprehensive genomic profiling of over 10,000 advanced solid tumors. Oncotarget. 2025 07 25; 16:587-603.
Score: 0.006
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y, Gandara D. Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2025 Jun; 9:e2400640.
Score: 0.005
-
Diergaarde B, Young G, Hall DW, Mazloom A, Costa GL, Subramaniam S, Palomares MR, Garces J, Baehner FL, Schoen RE. Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The a-CORRECT Study. J Surg Oncol. 2025 Jul; 132(1):175-186.
Score: 0.005
-
Kundranda MN, Kemkes AC, Evans MC, Flannery CA, Hall DW, Hoag JR, Therala N, Thakkar SG, De La O JP. Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. Oncologist. 2024 09 06; 29(9):e1228-e1230.
Score: 0.005
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y. Value of next generation sequencing (NGS) testing in advanced cancer patients. J Med Econ. 2024 Jan-Dec; 27(1):519-530.
Score: 0.005
-
Kirkpatrick M, Hall DW. Male-biased mutation, sex linkage, and the rate of adaptive evolution. Evolution. 2004 Feb; 58(2):437-40.
Score: 0.005
-
Gibbs SN, Peneva D, Cuyun Carter G, Palomares MR, Thakkar S, Hall DW, Dalglish H, Campos C, Yermilov I. Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer. JCO Precis Oncol. 2023 06; 7:e2200715.
Score: 0.005
-
Vranic S, Basu GD, Hall DW, Gatalica Z. Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. Acta Med Acad. 2022 Dec; 51(3):217-231.
Score: 0.005
-
Higgins DM, Lowry EG, Kanizay LB, Becraft PW, Hall DW, Dawe RK. Fitness Costs and Variation in Transmission Distortion Associated with the Abnormal Chromosome 10 Meiotic Drive System in Maize. Genetics. 2018 01; 208(1):297-305.
Score: 0.003
-
Bewick AJ, Hofmeister BT, Lee K, Zhang X, Hall DW, Schmitz RJ. FASTmC: A Suite of Predictive Models for Nonreference-Based Estimations of DNA Methylation. G3 (Bethesda). 2015 Dec 17; 6(2):447-52.
Score: 0.003
-
Raman JD, Hall DW, Cadeddu JA. Renal ablative therapy: radiofrequency ablation and cryoablation. J Surg Oncol. 2009 Dec 15; 100(8):639-44.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|